Nevro Common Stock Total Equity from 2010 to 2025

NVRO Stock  USD 5.72  0.01  0.17%   
Nevro Corp Common Stock Total Equity yearly trend continues to be very stable with very little volatility. Common Stock Total Equity is likely to drop to about 28.1 K. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2013-12-31
Previous Quarter
35 K
Current Value
36 K
Quarterly Volatility
7.7 K
 
Yuan Drop
 
Covid
Check Nevro Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nevro Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.9 M, Interest Expense of 8.8 M or Selling General Administrative of 215.3 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0 or PTB Ratio of 2.26. Nevro financial statements analysis is a perfect complement when working with Nevro Corp Valuation or Volatility modules.
  
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Latest Nevro Corp's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Nevro Corp over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Nevro Corp's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nevro Corp's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Nevro Common Stock Total Equity Regression Statistics

Arithmetic Mean24,147
Geometric Mean13,329
Coefficient Of Variation59.14
Mean Deviation11,573
Median30,000
Standard Deviation14,279
Sample Variance203.9M
Range39.2K
R-Value0.84
Mean Square Error64.8M
R-Squared0.70
Significance0.000049
Slope2,516
Total Sum of Squares3.1B

Nevro Common Stock Total Equity History

202528.1 K
202440.2 K
202035 K
201932 K
201730 K
201629 K
201528 K

About Nevro Corp Financial Statements

Nevro Corp investors utilize fundamental indicators, such as Common Stock Total Equity, to predict how Nevro Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Common Stock Total Equity40.2 K28.1 K
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.87)
Revenue Per Share
11.404
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.09)
Return On Equity
(0.25)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.